atherosclerosis

January 27, 2020

A new contributor to atherosclerosis

Sean Davies and colleagues are exploring lipid aldehydes produced during oxidative stress and their contribution to HDL dysfunction and atherosclerosis.

By Leigh MacMillan
From left, Ryan Allen, PhD, MacRae Linton, MD, Kasey Vickers, PhD, Quanhu Sheng, PhD, and colleagues are working to create a new model of atherosclerosis development. (photo by Susan Urmy)
August 26, 2019

VUMC investigators receive Keck Foundation award for novel atherosclerosis research

A team of researchers has received a $1 million grant from the W.M. Keck Foundation to explore a novel model of atherosclerosis development.

By Leigh MacMillan
July 24, 2019

Heart Institute offering new option to clear carotid arteries

Vanderbilt Heart and Vascular Institute is now offering a new procedure that reduces stroke risk for many high-risk patients during interventions for extracranial carotid disease

By Matt Batcheldor
July 11, 2019

New look at atherosclerosis

A new imaging method makes it possible to directly measure cell division and changes in metabolism in atherosclerotic plaques.

By Sanjay Mishra
June 29, 2018

Scavengers “protect” HDL

Jun. 29, 2018—Lipid molecules that bind to HDL can modify its function — and blocking that modification can protect HDL and potentially lower the risk of atherosclerosis and heart disease.

By Bill Snyder
April 9, 2015

Team sees success clearing blocked coronary arteries

When atherosclerosis develops in the coronary arteries over a period of time, complete blockage of that artery can result in chest pain, shortness of breath and decreased quality of life.

By Kathy Whitney
December 17, 2014

Target for atherosclerosis therapies

A newly identified “atheroprotective” gene is a tool for exploring plaque pathophysiology and may be a good target for therapies to slow atherosclerosis progression.
By Leigh MacMillan
November 25, 2014

Protein implicated in atherosclerosis

Vanderbilt researchers have discovered a new target for the prevention of atherosclerotic plaque development and cardiovascular disease.
By VUMC News and Communications
August 21, 2014

Major grant spurs deeper look into ‘good cholesterol’

In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis.
By Bill Snyder
April 18, 2013

Early study reveals ‘nuclear’ strategy for atherosclerosis

Vanderbilt University scientists have discovered a potential new strategy for lowering cholesterol and triglyceride levels and stopping atherosclerosis and fatty liver disease.
By Bill Snyder
December 8, 2011

Move out, cholesterol

Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis.
By Leigh MacMillan
1 2